CPSS insider Charles Bradley granted 300,000 options at $8.19
Charles E. Bradley Jr., who serves as CEO, a director and a >10% owner of Consumer Portfolio Services (CPSS), received a grant of 300,000 stock options with an exercise price of $8.19.
Rhea-AI Filing Summary
Charles E. Bradley Jr., who serves as CEO, a director and a >10% owner of Consumer Portfolio Services (CPSS), received a grant of 300,000 stock options with an exercise price of $8.19. The options were issued in consideration of his services and were dated 09/09/2025. They become exercisable in four equal annual installments beginning on 09/09/2026 and fully vest by 09/09/2029, and expire on 09/09/2032. The Form 4 reports the reporting person holds 300,000 underlying common shares on a direct basis following the transaction.
Positive
- Alignment of interests: Option grant vests over four years, which links CEO compensation to long-term shareholder value.
- Significant direct stake: Reporting person is a CEO, director and >10% owner, increasing management’s alignment with investors.
Negative
- Potential dilution: The 300,000 underlying shares could dilute existing shareholders if the options are exercised.
- At-the-market risk: If the market price remains below the $8.19 strike, the options may provide limited retention value until share price increases.
Insights
Insider option grant aligns executive pay with long-term company performance.
The grant to the CEO of 300,000 options at an $8.19 strike vests over four years, which is a common structure to retain senior leadership and tie compensation to future share-price performance. Because Bradley is a >10% owner and a director, the award increases his direct economic stake and aligns his interests with shareholders. The options were issued for services rather than purchased, indicating a compensation award rather than personal investment.
Material insider grant, but not an immediate dilution event until exercised.
The instrument is a non‑derivative stock option grant covering 300,000 shares with a defined $8.19 exercise price and a 2032 expiration. It will not dilute existing shareholders until exercise; however, it represents potential future dilution. Vesting over 2026–2029 phases the economic impact and provides retention incentives. The Form 4 shows direct beneficial ownership of the underlying 300,000 shares following issuance.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 300,000 | $0.00 | $0.00 |
Footnotes (2)
- F1. Becomes exercisable in four equal installments on 9/9/2026, 9/9/2027, 9/9/2028, and 9/9/2029.
- F2. Issued in consideration of the named person's services to the issuer.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transaction did CPSS insider Charles E. Bradley Jr. report?
How do the options vest for the CPSS CEO grant?
What is the expiration date of the awarded options?
Was the option grant purchased or issued for services?
Does the Form 4 show Bradley’s ownership after the transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.